Primary glomerulonephritis as a cause of non-systemic immunological diseases
Abstract
Introduction: Primary glomerulonephritis is restricted to the kidney, with an immunological basis, they are diagnosed, classified, and treated thanks to renal puncture biopsy, it is necessary to establish them as a differential diagnosis of secondary glomerulonephritis.
Objectives: To know the most frequent types of primary glomerulonephritis at the Hospital de Clínicas. To evaluate the form of clinical presentation and the clinical-pathological correlation of primary glomerulonephritis at the Hospital de Clínicas and to determine the more common biopsy indications, and the frequency and type of complications of kidney biopsy puncture.
Patients and methods: Retrospective, descriptive cross-sectional study, 38 records of renal biopsies performed at the Hospital de Clínicas in patients over sixteen years of age were reviewed, from October 2014 to August 2015. The following were evaluated: age, sex, the indication for the biopsy, and complications. In addition: creatinine, creatinine clearance, and anatomopathological determination.
Results: Primary glomerulonephritis represents 42% of all biopsies performed. 38 were primary glomerulonephritis. The patient’s mean age was 35.3 ± 14.6 years, and 62% were female. 75% had arterial hypertension, mean creatinine was 2.1 mg/dL, and clearance was 80.6±34.6 mL/min (median: 89.5 mL/min; range: 5-130 mL/min). The more common indica tion was nephrotic syndrome (NS) 69%. 75% did not present complications, the most frequent diagnosis was membranous-proliferative glomerulonephritis (MPGN) 37% followed by membranous nephropathy (GNM) 25%.
Conclusion: Nephrotic syndrome was the most frequent presentation and clinical indication for PBR. The most common types of primary glomerulonephritis were membranoprolife-rative glomerulonephritis (37%) and membranous glomerulonephritis (25%). PBR is a safe diagnostic method.
Downloads
References
(2) Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations ex posed by validation studies, and suggestions for modification. Kidney Int. abril de 2014;85(4):779-93.
(3) Comprehensive Clinical Nephrology - 9780323479097 [Internet]. US Elsevier Health. [citado 31 de octubre de 2022]. Disponible en: https://www.us.elsevierhealth.com/comprehensive-clinical- nephrology-9780323479097.html
(4) Primary Glomerular Disease - Brenner and Rector’s The Kidney, 8th ed [Internet]. [citado 31 de octubre de 2022]. Disponible en: https://doctorlib.info/nephrology/kidney/31.html
(5) Kasamatsu E, Nunes VM, Morán M, Centurión M, Campos de Alvarenga S. Glomerulopatías en el Paraguay. Reporte del Registro de Biopsias Renales en 1072 casos. Mem Inst Investig En Cienc Salud. diciembre de 2005;3(1):51-7.
(6) ovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. octubre de 2021;100(4):S1-276.
(7) Hurtado A, Escudero E, Stromquist CS, Urcia J, Hurtado ME, Gretch D, et al. Distinct patterns of glomerular disease in Lima, Peru. Clin Nephrol. mayo de 2000;53(5):325-32.
(8) Mazzuchi N, Acosta N, Caorsi H, Schwedt E, Di Martino LA, Mautone M, et al. [Frequency of diagnosis and clinic presentation of glomerulopathies in Uruguay]. Nefrol Publicacion Of Soc EspanolaNefrol. 2005;25(2):113-20.
(9) Mazzarolo Cruz HM, Cruz J, Silva AL, Saldanha LB, de Oliveira Penna D. Prevalence of adult primary glomerular diseases: retrospective analysis of 206 kidney biopsies (1990-1993). Rev Hosp Clin. febrero de 1996;51(1):3-6.
(10) Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. septiembre de 2004;66(3):920-3.
(11) López-Gómez JM, Rivera F. Registro de glomerulonefritis de la Sociedad Española de Nefrología en 2019: pasado, presente y nuevos retos. Nefrología. 1 de julio de 2020;40(4):371-83.
(12) Oliveira MC, Flores FDS, Barbosa FM, Fujii CDC, Rabelo-Silva ER, Lucena A de F. Evaluation of percutaneous renal biopsy complications based on outcomes and indicators of the Nursing Outcomes Classification. Rev Lat Am Enfermagem. 2021;29:e3415.
(13) Biopsia Renal | Nefrología al día [Internet]. [citado 31 de octubre de 2022]. Disponible en: https://www.nefrologiaaldia.org/es- articulo-biopsia-renal-234
Copyright (c) 2022 Paraguayan Journal of Rheumatology

This work is licensed under a Creative Commons Attribution 4.0 International License.